表紙
市場調查報告書
商品編碼
934319

血漿療法的全球市場:新型冠狀病毒感染疾病(COVID-19)的影響(2020年∼2024年)

Global Plasma Therapy Market (Pure PRP, Leukocyte-Rich PRP, Pure PRF, Leukocyte-Rich PRF): Insights & Forecast with Potential Impact of COVID-19 (2020-2024)

出版日期: | 出版商: Koncept Analytics | 英文 120 Pages | 訂單完成後即時交付

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球血漿療法市場,從2020年到2024年以7.24%的年複合成長率成長,預計達到3億4,894萬美元。 醫療費的增加,整形外科疾病發生增加,老年人口的增加,慢性疾病的盛行率增加,都市化的擴大,對非外科的治療的偏好度等成為促進市場成長的要素,但嚴重的副作用等成為阻礙因素。還有男性荷爾蒙性脫髮症的患者數增加,COVID-19大流行病伴隨的需求擴大,已開發國家的更佳醫療保健提供,技術進步等要素也不容忽視。血漿療法,有純PRP(多血小板血漿),富白血球PRP,純PPRF(多血小板纖維蛋白),富白血球PRF(L-PRF)。

本報告提供全球血漿療法市場調查,COVID-19大流行病的影響,全球市場分析,各地區市場分析,市場力學,競爭情形,企業簡介等資訊。

目錄

第1章 市場概要

  • 簡介
  • 血漿療法
  • 血小板濃縮液的種類
  • 用血漿蛋白質療法治療的稀少疾病
  • 日常醫療的血漿療法的使用

第2章 COVID-19的影響

  • 經濟影響
  • 醫療保健部門的影響
  • 有機流量的變化
  • 血漿療法的影響
  • 對血漿療法的需求劇增
  • 地區方案

第3章 全球市場分析

  • 全球血漿療法市場
  • 全球血漿療法市場預測
  • 各類型的市場
    • 純PRP
    • 財富白血球PRP
    • 純PRF
    • 財富白血球PRF(L-PRF)
  • 各來源的市場
    • 自體血漿
    • 同類血漿
  • 各用途的市場
    • 整形外科
    • 皮膚科
    • 心臟肌肉損傷
  • 各終端用戶的市場
    • 醫院及醫院
    • 研究機關
  • 各地區的市場

第4章 地區市場分析

  • 北美
  • 歐洲
  • 亞太地區
  • 其他

第5章 市場動態

  • 成長要素
    • 醫療費的增加
    • 整形外科疾病的發生增加
    • 老年人口的增加
    • 治療的認識提高
    • 慢性疾病的盛行率的上升
    • 擴大的都市化
    • 非外科的治療的偏好度
  • 主要的趨勢和開發
    • 科技的進步
    • 各冠狀病毒龐大的需求
    • 雄性脫毛症患者的擴大
    • 已開發國家的更佳醫療提供
    • 捐血的重要性相關意識的高漲
  • 課題
    • 血漿療法嚴重的副作用
    • 實行的障礙
    • 血漿療法相關的高成本

第6章 競爭情形

  • 全球市場
    • 主要業者的收益比較
    • 主要業者的市值比較
    • 主要業者的研究開發比較
    • 各公司的佔有率

第7章 企業簡介

  • Takeda Pharmaceutical Company Limited
    • 事業概要
    • 財務概要
    • 事業策略
  • CSL Limited
    • 事業概要
    • 財務概要
    • 事業策略
  • Grifols, S.A.
    • 事業概要
    • 財務概要
    • 事業策略
  • Octapharma AG
    • 事業概要
    • 財務概要
    • 事業策略
  • Biotest AG
    • 事業概要
    • 財務概要
    • 事業策略
  • LFB SA
    • 事業概要
    • 事業策略
目錄

The global plasma therapy market is expected to reach US$384.94 million in 2024, witnessing growth at a CAGR of 7.24%, over the period 2020-2024. Factors such as rising healthcare expenditure, increasing occurrences of orthopedic disorders, growing geriatric population, rising prevalence of chronic diseases, expanding urbanization and growing preference towards non-surgical procedures are expected to drive the market. The growth of the market would be challenged by severe side effects of plasma therapy and barriers to implementation. A few notable trends may include escalating androgenic alopecia patients, huge demand due to coronavirus, better healthcare provision in developed countries and advancements in technology.

The global plasma therapy market can be categorized on the basis of type, source, application and end-users. Depending upon the type, the global plasma therapy market can be categorized into Pure PRP (Platelet Rich Plasma), Leukocyte Rich PRP, Pure Platelet Rich Fibrin (PRF) and Leukocyte Rich Fibrin (L-PRF). In terms of source, the global plasma therapy market can be segmented into Autologous and Allogenic. Whereas, on the basis of application, the global plasma therapy market can broadly be categorized into Orthopedic, Dermatology, and Cardiac Muscle Injury. And the global plasma therapy market can be segmented into Hospitals & Clinics and Research Institutes, depending upon the end-user.

The fastest growing regional market is North America due to advanced infrastructure which helped in increasing plasma collection over the time, rise in the occurrence of several orthopedic disorders such as osteoarthritis, easy availability of therapeutics were the factors responsible for market growth in the abovementioned time period.

Scope of the report:

  • The report provides a comprehensive analysis of the global plasma therapy market segmented on the basis of type, source, application and end-users.
  • The major regional and country markets (North America, Europe, Asia Pacific and Rest of the World) have been analyzed.
  • The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.
  • The competitive landscape of the market, along with the company profiles of leading players (Takeda Pharmaceutical Company Limited, CSL Limited, Grifols, S.A., Octapharma AG, Biotest AG and LFB S.A.) are also presented in detail.

Key Target Audience:

  • Platelet-rich Plasma (PRP) Manufacturers and Suppliers
  • Plasma Therapy Service/Equipment Providers and Distributors
  • End Users (Hospitals & Clinics and Medical Research Institutes)
  • Government Bodies & Regulating Authorities

Table of Contents

1. Market Overview

  • 1.1 Introduction
  • 1.2 Plasma Therapy
  • 1.3 Types of Platelet Concentrates
  • 1.4 Rare Diseases Treated by Plasma Protein Therapies
  • 1.5 Uses of Plasma Therapies in Everyday Medicine

2. Impact of COVID-19

  • 2.1 Economic Impact
  • 2.2 Impact on Healthcare Sector
  • 2.3 Change in Organic Traffic
  • 2.4 Impact on Plasma Therapy
  • 2.5 Demand Surge for Plasma Therapy
  • 2.6 Regional Scenario

3. Global Market Analysis

  • 3.1 Global Plasma Therapy Market by Value
  • 3.2 Global Plasma Therapy Market Forecast by Value
  • 3.3 Global Plasma Therapy Market by Type
    • 3.3.1 Global Pure PRP Therapy Market by Value
    • 3.3.2 Global Pure PRP Therapy Market Forecast by Value
    • 3.3.3 Global Leukocyte Rich PRP Therapy Market by Value
    • 3.3.4 Global Leukocyte Rich PRP Therapy Market Forecast by Value
    • 3.3.5 Global Pure Platelet Rich Fibrin (PRF) Therapy Market by Value
    • 3.3.6 Global Pure Platelet Rich Fibrin (PRF) Market Forecast by Value
    • 3.3.7 Global Leukocyte Rich Fibrin (L-PRF) Therapy Market by Value
    • 3.3.8 Global Leukocyte Rich Fibrin (L-PRF) Therapy Market Forecast by Value
  • 3.4 Global Plasma Therapy Market by Source
    • 3.4.1 Global Autologous Plasma Therapy Market by Value
    • 3.4.2 Global Autologous Plasma Therapy Market Forecast by Value
    • 3.4.3 Global Allogenic Plasma Therapy Market by Value
    • 3.4.4 Global Allogenic Plasma Therapy Market Forecast by Value
  • 3.5 Global Plasma Therapy Market by Application
    • 3.5.1 Global Orthopedic Plasma Therapy Market by Value
    • 3.5.2 Global Orthopedic Plasma Therapy Market Forecast by Value
    • 3.5.3 Global Dermatology Plasma Therapy Market by Value
    • 3.5.4 Global Dermatology Plasma Therapy Market Forecast by Value
    • 3.5.5 Global Cardiac Muscle Injury Plasma Therapy Market by Value
    • 3.5.6 Global Cardiac Muscle Injury Plasma Therapy Market Forecast by Value
  • 3.6 Global Plasma Therapy Market by End-User
    • 3.6.1 Global Hospitals & Clinics Plasma Therapy Market by Value
    • 3.6.2 Global Hospitals & Clinics Plasma Therapy Market Forecast by Value
    • 3.6.3 Global Research Institutes Plasma Therapy Market by Value
    • 3.6.4 Global Research Institutes Plasma Therapy Market Forecast by Value
  • 3.7 Global Plasma Therapy Market by Region

4. Regional Market Analysis

  • 4.1 North America
    • 4.1.1 North America Plasma Therapy Market by Value
    • 4.1.2 North America Plasma Therapy Market Forecast by Value
  • 4.2 Europe
    • 4.2.1 Europe Plasma Therapy Market by Value
    • 4.2.2 Europe Plasma Therapy Market Forecast by Value
  • 4.3 Asia Pacific
    • 4.3.1 Asia Pacific Plasma Therapy Market by Value
    • 4.3.2 Asia Pacific Plasma Therapy Market Forecast by Value
  • 4.4 RoW
    • 4.4.1 RoW Plasma Therapy Market by Value
    • 4.4.2 RoW Plasma Therapy Market Forecast by Value

5. Market Dynamics

  • 5.1 Growth Drivers
    • 5.1.1 Rising Healthcare Spending
    • 5.1.2 Increasing Occurrences of Orthopedic Disorders
    • 5.1.3 Growing Geriatric Population
    • 5.1.4 Increasing Awareness about Treatment
    • 5.1.5 Rising Prevalence of Chronic Diseases
    • 5.1.6 Expanding Urbanization
    • 5.1.7 Growing Preference Towards Non-Surgical Procedures
  • 5.2 Key Trends and Developments
    • 5.2.1 Advancements in Technology
    • 5.2.2 Huge Demand due to Coronavirus
    • 5.2.3 Escalating Androgenic Alopecia Patients
    • 5.2.4 Better Healthcare Provision in Developed Countries
    • 5.2.5 Rising Awareness regarding Importance of Blood Donation
  • 5.3 Challenges
    • 5.3.1 Severe Side Effects of Plasma Therapy
    • 5.3.2 Barriers to Implementation
    • 5.3.3 High Cost Associated with Plasma Therapy

6. Competitive Landscape

  • 6.1 Global Market
    • 6.1.1 Revenue Comparison of Key Players
    • 6.1.2 Market Capitalization Comparison of Key Players
    • 6.1.3 R&D Comparison of Key Players
    • 6.1.4 Global Plasma Therapy Product Sales Volume Share by Company

7. Company Profiles

  • 7.1 Takeda Pharmaceutical Company Limited
    • 7.1.1 Business Overview
    • 7.1.2 Financial Overview
    • 7.1.3 Business Strategies
  • 7.2 CSL Limited
    • 7.2.1 Business Overview
    • 7.2.2 Financial Overview
    • 7.2.3 Business Strategies
  • 7.3 Grifols, S.A.
    • 7.3.1 Business Overview
    • 7.3.2 Financial Overview
    • 7.3.3 Business Strategies
  • 7.4 Octapharma AG
    • 7.4.1 Business Overview
    • 7.4.2 Financial Overview
    • 7.4.3 Business Strategies
  • 7.5 Biotest AG
    • 7.5.1 Business Overview
    • 7.5.2 Financial Overview
    • 7.5.3 Business Strategies
  • 7.6 LFB S.A.
    • 7.6.1 Business Overview
    • 7.6.2 Business Strategies

List of Figures

  • Proteins Present in Plasma
  • Process of Plasma Therapy
  • Rare Diseases Treated by Plasma Protein Therapies
  • Uses of Plasma in Everyday Medicine
  • Breakdown of Direct and Indirect Costs of COVID-19 (2020)
  • Organic Traffic Growth or Decline due to COVID-19 (2020)
  • Global Increase in COVID-19 Cases (2020)
  • Global Plasma Therapy Market by Value (2015-2019)
  • Global Plasma Therapy Market Forecast by Value (2020-2024)
  • Global Plasma Therapy Market by Drug Type (2019)
  • Global Pure PRP Therapy Market by Value (2015-2019)
  • Global Pure PRP Therapy Market Forecast by Value (2020-2024)
  • Global Leukocyte Rich PRP Therapy Market by Value (2015-2019)
  • Global Leukocyte Rich PRP Therapy Market Forecast by Value (2020-2024)
  • Global Pure Platelet Rich Fibrin (PRF) Therapy Market by Value (2015-2019)
  • Global Pure Platelet Rich Fibrin (PRF) Market Forecast by Value (2020-2024)
  • Global Leukocyte Rich Fibrin (L-PRF) Therapy Market by Value (2015-2019)
  • Global Leukocyte Rich Fibrin (L-PRF) Therapy Market Forecast by Value (2020-2024)
  • Global Plasma Therapy Market by Source (2019)
  • Global Autologous Plasma Therapy Market by Value (2015-2019)
  • Global Autologous Plasma Therapy Market Forecast by Value (2020-2024)
  • Global Allogenic Plasma Therapy Market by Value (2015-2019)
  • Global Allogenic Plasma Therapy Market Forecast by Value (2020-2024)
  • Global Plasma Therapy Market by Application (2019)
  • Global Orthopedic Plasma Therapy Market by Value (2015-2019)
  • Global Orthopedic Plasma Therapy Market Forecast by Value (2020-2024)
  • Global Dermatology Plasma Therapy Market by Value (2015-2019)
  • Global Dermatology Plasma Therapy Market Forecast by Value (2020-2024)
  • Global Cardiac Muscle Injury Plasma Therapy Market by Value (2015-2019)
  • Global Cardiac Muscle Injury Plasma Therapy Market Forecast by Value (2020-2024)
  • Global Plasma Therapy Market Value by End-User (2019)
  • Global Hospitals & Clinics Plasma Therapy Market by Value (2015-2019)
  • Global Hospitals & Clinics Plasma Therapy Market Forecast by Value (2020-2024)
  • Global Research Institutes Plasma Therapy Market by Value (2015-2019)
  • Global Research Institutes Plasma Therapy Market Forecast by Value (2020-2024)
  • Global Plasma Therapy Market Value by Region (2019)
  • North America Plasma Therapy Market by Value (2015-2019)
  • North America Plasma Therapy Market Forecast by Value (2020-2024)
  • Europe Plasma Therapy Market by Value (2015-2019)
  • Europe Plasma Therapy Market Forecast by Value (2020-2024)
  • Asia Pacific Plasma Therapy Market by Value (2015-2019)
  • Asia Pacific Plasma Therapy Market Forecast by Value (2020-2024)
  • RoW Plasma Therapy Market by Value (2015-2019)
  • RoW Plasma Therapy Market Forecast by Value (2020-2024)
  • Global Healthcare Spending Per Capita (2015-2019)
  • Global Hip & Knee Osteoarthritis Cases (1990-2020)
  • Global Population Above 65 Years (2015-2019)
  • Global Literacy Rate (2015-2019)
  • Number of People with Chronic Conditions in the U.S. (2010-2030)
  • Global Urban Population (2014-2019)
  • Global Plasma Therapy Product Sales Volume Share by Company (2019)
  • Takeda Pharmaceutical Company Limited Revenue and Net Profit (2015-2019)
  • Takeda Pharmaceutical Company Limited Revenue by Region (2019)
  • CSL Limited Total Revenue and Net Profit (2015-2019)
  • CSL Limited Total Revenue by Segment (2019)
  • CSL Limited Total Revenue by Region (2019)
  • Grifols, S.A. Net Revenue and Profit (2015-2019)
  • Grifols, S.A. Net Revenue by Segment (2019)
  • Grifols, S.A. Net Revenue by Region (2019)
  • Octapharma AG Revenue and Net Profit (2015-2019)
  • Biotest AG Revenue and Profit (2015-2019)
  • Biotest AG Revenue by Segment (2019)
  • Biotest AG Revenue by Region (2019)

List of Tables

  • Severe Side-Effects of Protein Rich Plasma Therapy
  • Revenue Comparison of Key Players (2019)
  • Market Capitalization Comparison of Key Players (2020)
  • R&D Expenditure Comparison of Key Players (2019)